Enhanced inhibition of tumour growth and metastasis, and induction of antitumour immunity by IL-2-IgG2b fusion protein. | Scand J Immunol;55(5): 484-92, 2002 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Enhanced inhibition of tumour growth and metastasis, and induction of antitumour immunity by IL-2-IgG2b fusion protein.

Budagian, V; Nanni, P; Lollini, P L; Musiani, P; Di Carlo, E; Bulanova, E; Paus, R; Bulfone-Paus, S.

Affiliation

Budagian V; Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany.

Scand J Immunol ; 55(5): 484-92, 2002 May.

Article in En | MEDLINE | ID: mdl-11975760

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin G / Adenocarcinoma / Interleukin-2 / Mammary Neoplasms, Experimental Limits: Animals Language: En Journal: Scand J Immunol Year: 2002 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin G / Adenocarcinoma / Interleukin-2 / Mammary Neoplasms, Experimental Limits: Animals Language: En Journal: Scand J Immunol Year: 2002 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido